Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications

Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications

Abstract Background Fingolimod, an immunomodulatory agent, is used for the treatment of relapsing–remitting multiple sclerosis (RRMS). Fingolimod-associated macular edema (FAME) is a known complication with an incidence of 0.4%. The current recommendation for treatment of FAME is cessation of fingol...

Full description

Bibliographic Details
Main Authors: Rachel Husmann, John B. Davies, Malik Ghannam, Brent Berry, Praful Kelkar
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Clinical and Molecular Allergy
Subjects:
Multiple sclerosis
Fingolimod
Retina
Macular edema
Nonsteroidal anti-inflammatory eye drops
Online Access:http://link.springer.com/article/10.1186/s12948-020-00119-4

Internet

http://link.springer.com/article/10.1186/s12948-020-00119-4

Similar Items